Superdry – this recovering group offers massive upside as it continues to get things right again

Members of my family are, but I am not, particularly concerned with sustainability – but then I can defend my stance (if I have to) by noting my senior years, meaning I have not got many still left to go, compared to them.

However, I have to say that I was impressed by the Superdry (LON:SDRY) commitment to sustainability and driving it through its product lines by significant contact with its suppliers as it urges them to be organic.

A very strong commitment to sustainability

Last Friday’s announcement of the final results for the year to end April noted very clearly that:

“Our mission is ‘To be the #1 sustainable style destination’ through our distinct collections, defined by consumer style choices. We design affordable, premium quality clothing, accessories and footwear which are sold around the world. We have a clear strategy for delivering continued growth via a multi-channel approach combining Stores, Ecommerce, and Wholesale.”

Examples of the way it looks to drive its sustainability focus in “underpinning everything we do” are shown by the fact that 47% of the products that it bought for sale in its Autumn/Winter 2021 and Spring/Summer 2022 collections were made of sustainable product, compared to just 33% for the previous year.

Of the products that it sold in the 2022 full year, sustainables were some 46% against 35% previously.

For Superdry sustainability continued to sit at the heart of its business, especially in its sourcing. 

Cotton seeds and recycled bottles

It has a target of converting 20,000 farmers in India to organic practices and using 100% organic cotton in its garments by 2025. 

As at the end of FY22, it had invested in training to convert 7,508 farmers, up from 5,684 last year and in the process donated over 65m organic cotton seeds

For its Spring/Summer 2022 collection 99% of its swimwear was converted to recycled materials, with50.4m recycled bottles having been used to produce both its Spring/Summer 2022 swimwear and also in the company’s Autumn/Winter 2021 and Spring/Summer 2022 range of outerwear jacket fill.

City Reaction – is it sustainable?

After the £93m capitalised group’s results were published there were many observers who commented upon whether the company itself had any sustainability.

Even so the group’s shares responded with an 11% jump in its share price to close at 114p.

In the last year or so the group’s shares saw a peak last November at 330p but they subsequently traded down to a 96p low, just two weeks ago.

Not a straight line

Like businesses everywhere Superdry has had its ups and downs. 

Julian Dunkerton built the business up from a Cheltenham market stall to getting his stores group quoted in 2010. The bubble was burst with a profit warning in 2012 alongside a suspension of its store opening programme.

Dunkerton left the board in late 2014 and two years later sold 4m shares at £12 each, then leaving him as the biggest holder with a 27% stake in the business.

By 2019 he declared openly that he did not like the way the group was being run, without him on the board. 

He won his seat back on the board while fellow directors resigned.

His mission was ‘to reset the brand’s focus on design and quality’.

From an interim CEO position, he was six months later promoted to that post permanently, but sales were falling due to his decision to minimise promotions, dropping in-store discounts while focussing upon full-price sales.

Then Covid-19 happened in Spring 2020 and the severe fall in sales revenues needed drastic action.

The 2021 trading year saw takings fall 21% to £556m, but with the group going into a smaller loss of £36.7m (loss £166.9m in 2020).

Overall, the group’s mission today is ‘to inspire and engage style-obsessed consumers, while leaving a positive environmental legacy.’

The recent results – still a going concern

The full year to end April saw sales up 9.6% at £609.6m, with the adjusted pre-tax loss of £12.6m in 2021 being replaced by a much healthier £21.9m profit, boosting earnings from a loss of 19.4p to a plus 36.3p per share.

The group’s asset backed lending facility runs out in January next year, so there are ongoing discussions to refine and renew the position.

Thoughts that it may have problems continuing as a ‘going concern’ resurfaced but have been subsequently played down.

CEO Julian Dunkerton, stated that:

“These are exceptional times for retail and for the economy more generally, and like all brands we’re having to work harder than ever to drive performance. Against that backdrop, I am pleased that we managed to return the business to full-year profit, driven by increased full price sales, whilst also making strong strategic progress. I’m proud of the strides our team has made, delivering great product while also making a step-change in our social and digital capabilities and real progress towards our sustainability objectives.

“Superdry is a premium, affordable, brand, which should mean we are well-positioned as customers think more carefully about their purchases. That said, given the current challenging conditions, we continue to run the business prudently while remaining focused on delivering our strategic goals.”

With the results the group posted details of the 22-week period to 1 October showing sales had improved another 7%, while also noting that there were sector-wide trends of traffic slowly moving away from online back to store. Encouragingly the group’s wholesale revenue has increased year-on-year.

Despite the sales increase, it is apparent that margins are a lot tighter, so the group may only make between £10m to £20m for the adjusted pre-tax profits to end April 2023.

Analysts Opinion – 500p Target Price

At Liberum Capital, broker to the group, their analyst Wayne Brown is rating the shares as a Buy, with a Target Price of 500p a share.

His estimates for the current year to end April 2023 are for sales of £652m (£610m) a dip in profits to £16.3m (£21.9m), generating earnings of 15.1p (36.3p) and paying a resumed dividend of 5.0p per share (nil).

Already his figures suggest sales of £698m next year, with £26.3m profits, 24.5p earnings and a useful 8.2p per share in dividend.

Further out he is anticipating £748m sales, £41.1m profits, 38.2p earnings and a 12.7p dividend.

His Target Price, based upon his estimates, does not look so outlandish.

Conclusion – a potential doubling of price?

Last week’s results clearly show that Julian Dunkerton has got firmer control of Superdry’s reins and is determined to return the group to trade around its former glories.

The iconic brand, which is sold to 157 countries globally, is known the world over and with ‘sustainability’ as its mantra going forward it is a fair bet, facility permitting, that he will deliver again, which will be glorious news for its shares, now at just 114p.

The AGM is due at the end of October, while the pre-close trading Update for the first half-year will be declared in November, giving a few more weeks of cheap buying of the group’s shares.

A 500p Target Price may be too far away for most investors but a doubling in price over the next year is quite feasible.

Sterling falls despite increased Bank of England intervention

The pound fell against the dollar on Monday despited the Bank of England ratcheting up their daily bond purchases for the remainder of their support package.

GBP/USD fell to 0.37% to 1.1052 as the Bank of England announced they would increase daily bond purchases to £10bn from £5bn.

“I’m not so sure that this is a good sign to be frank. We should remember that market interventions of this type by the central bank are not normal. It is extraordinary and the fact the BoE needs to increase the daily level of liquidity for its remaining five auctions shows that its initial interventions were unsatisfactory,” said Joshua Raymond, Director at financial brokerage XTB.

The Bank of England stepped into the UK gilt market to support yields following the announcement of the UK government’s radical fiscal package that led to severe volatility in bonds and the pound.

With the pound falling today, investors will be concerned about how the market will react to the removal of the BoE measures on Friday.

“While this programme is designed to provide calm to the markets following concerns about pension funds dumping gilts on the market, the fact it has doubled the previous limit of £5 billion also acts as a reminder that we’re living in unsettled times,” said Russ Mould, investment director at AJ Bell.

DS Smith shares jump 10% as full year guidance increased

In a brief statement released on Monday, DS Smith said they expected full year performance would be above their prior expectations.

The packaging and recycling company said operating profit would be at least £400m and saw strong cash generation.

Miles Roberts, DS Smith, Group Chief Executive, was upbeat and confident about navigating the current macro environment.

“I am very pleased with the performance in the year to date and the momentum in our business. We remain focussed on delivering for our customers and managing our costs in an inflationary environment. While the macro-economic outlook remains uncertain, performance this year is ahead of our previous expectations and we look forward to the remainder of the year with confidence,” said Miles Roberts.

DS Smith shares were 10% higher at the time of writing.

Lloyds shares: 3 reasons to buy at current levels

Just as Lloyds shares were starting to build some momentum on the back of higher interest rates, Liz Truss and her new government stopped the bank’s rally in its tracks.

Recent declines in Lloyds share price were a result of Kwarteng and Truss’s failed attempt to be fiscally radical, and a massive vote of no confidence by the markets. 

The pound has been the main barometer of the markets’ views on their fiscal, but underlying gilts yields have sent waves through the UK’s financial system, and damaged the value of FTSE 100 asset managers and banks.

Today, we consider three reasons why Lloyds shares on particular could be a buy after the recent sell off. 

Lloyds dividend

The promise of an attractive dividend to compensate for a wait for capital appreciation will almost always secure the interest of income investors.

With a dividend yield of 4.7% and dividend cover of 3.9x, Lloyds shares have both a strong yield and the capability of increasing dividends in the future.

Interest rates are set to rise

Disruption in the mortgage market will likely mean Lloyds sets aside provisions for bad debt in their next trading statement.

However, this is probably now largely priced in and investors may see a welcome uptick in Net Interest Margin (NIM) as a result of higher mortgages rates.

A key profitability metric for UK banks, Lloyds NIM will enjoy favourable upside pressures in the near term. Higher interest rates will also mean the future value of Lloyds loan book is worth more today.

Lloyds Price-to-Book valuation 

Banks saw the importance of their earnings as valuation metric diminish during the recovery from the financial crisis.

Ongoing litigation costs and changes to capital requirements meant profits were no longer the most appropriate measure of a bank’s financial health or future prospects.

Instead, the market shifted their attention to the bank’s assets and the potential change in book value of their assets. Thus, for some investors, price-to-book has a become the most scrutinised valuation metric for banks in recent years. 

Lloyds now trades at 0.6x book value, largely in the with the sector, but slightly below Lloyds average over the past few years.

There are still risks attached to Lloyds, including uncertainty around the housing market and general health of the UK economy, which has been reflected in the move down from 49p to 42p

Yet, with the Lloyds share price at 42p, and taking consideration the three points above, long term investors may take a cautiously optimistic approach to Lloyds shares, especially those with an appetite for income.

Why companies left AIM in September

There were five departures from AIM during September. One company was taken over, another moved to the Main Market and the other three decided to leave for various reasons.   
7 September 2022
Stanley Gibbons Group
Stamp dealer Stanley Gibbons has had a tough time in recent years. The largest shareholder Phoenix SG believed it was better to cancel the quotation considering the limited free float and additional costs. The 58% shareholder also said that it would reconsider its financial support if shareholders did not agree to the cancelation. Stanley Gibbons is loss making.
The busine...

Aquis weekly movers: Arbuthnot Banking ahead of expectations

1

Arbuthnot Banking Group (LON: ARBB) says full results should be ahead of market expectations of a £13m pre-tax profit. The third quarter trading statement says Arbuthnot Latham deposits exceed £3bn, although costs of deposits are rising. Base rate rises have a positive effect on results as changes to deposit rates lag the rises in interest rates. Credit criteria are being tightened, particularly for property. Assets under management are £1.35bn. The share price improved by 17.9% to 825p. Non-exec Sir Nigel Boardman acquired 9.749 shares at 810p each. Arbuthnot Banking non-voting shares (LON: ARBN) slipped 1.8% to 545p.

Clean Invest Africa (LON: CIA) bounced back after last week’s share price slump after its results announcement and was the best performer on the Aquis Stock Exchange last week with a rise of 62.5% to 0.325p. KR1 (LON: KR1) is another company that has recovered some of last week’s post-results loss, rising 8.45% to 38.5p.

RentGuarantor Holdings (LON: RGG) rose again at the beginning of the week. There were four trades on Monday – at least three were buys – and the highest price was 200p. There were no more trades during the week and the share price is 12.1% higher at 185p.

Hydrogen Future Industries (LON: HFI) has acquired a suite of international patents through a joint venture. The patents are relevant for the company’s wind-based hydrogen production system, plus other systems. The patents were issued to the vendor when it employed the boss of HFI’s development subsidiary. The payment will be £33,000 in cash, 5.2 million shares and 2.5 warrants exercisable at 12p each, with the second tranche of the payment dependent on the achievement of development milestones. The share price rose 10.5% to 5.25p.

Coinsilium (LON: COIN) chairman Malcolm Palle acquired 500,000 shares at 1.9p each, while chief executive Eddy Travia bought 500,000 shares at 1.95p each. The share price rose 8.11% to 2p.

National Milk Records (LON: NMRP) generated a 6% increase in 2021-22 revenues to £23.2m, while pre-tax profit improved from £1.65m to £2.22m. The dividend was raised by one-third to 2p a share. The milk recording and testing services increased revenues. The biggest increase was in genomics which rose from £292,000 to £488,000 and there is a potential launch in the US during 2023. The share price was 4.74% higher at 110.5p.

There has been a mineral resource upgrade at the Amapa iron project in Brazil, and shares in 27% shareholder Cadence Minerals (LON: KDR) rose 3.72% to 9.75p, even though there was profit-taking after the announcement. The updated resource at Amapa is 276Mt grading 38.33% Fe, up from 177Mt. The measured resource is 55Mt grading 39.26% Fe.  

Hydro Hotel, Eastbourne (LON: HYDP) reinstated the interim dividend at the rate of 14p a share. The share price rose 20p to 970p.

Director buying at Kent-based brewer Shepherd Neame (LON: SHEP) pushed the share price 0.4% higher at 672.5p. Richard Oldfield bought 6,000 shares at 675p a share and George Barnes acquired 3,200 shares at 672p each. The final dividend is 15p a share and the shares go ex-dividend on 13 October.

==========

Fallers

Goodbody Health (LON: GDBY) secured a distribution agreement with blood collection services provider Tasso Inc, which supplies virtually painless medical devices to draw a blood sample with no needles. Goodbody’s clinics will be able to extract more blood than from a finger prick. The share price fell 18.2% to 9p.

Invinity Energy Systems (LON: IES) has sold a 1.3MWh VS3 flow battery system for use in a datacentre in Arizona. Amati reduced its stake from 5.87% to 4.92%. The share price fell 8.8% to 23.25p.

AIM weekly movers: Trellus Health reduces cash burn

1

The new management team at Trellus Health (LON: TRLS) is reducing the cash burn and there should be nought cash until the end of 2024. Trellus Health intends to provide personalised care for people with chronic conditions with the initial focus being inflammatory bowel disease (IBD). The service offered is what the company calls resilience-driven connected health, which is about digital care delivery and patient monitoring. The first monthly subscribers have been enrolled and contracts with businesses are under negotiation. There was $24m in the bank at the end of June 2022 and there could still be net cash of $17m at the end of the year. The shares rose 86.2% to 13.5p, having reached the all-time low on the previous Friday.

N4 Pharma (LON: N4P) successfully completed initial in vitro testing of its Nuvec delivery system loaded with two generic siRNA probes at the same time. Both probes were able to significantly silence their respective targets. These positive test results will help discussions with potential partners. Work continues on a treatment for lung cancer. The N4 Pharma share price rose 58.5% to 3.25p.

Oxford Biodynamics (LON: OBD) is raising £9.1m via a placing at 20p a share and up to a further £2.95m could be raised through a one-for-6.81644 open offer. The share price rose 56.3% to 17.975p, which is still well below the placing price. This cash will help to fund the commercial development of the EpiSwitch CiRT technology. The EpiSwitch CiRT checkpoint inhibitor response test for cancer has been issued with a US reimbursement code earlier in the week.

Infectious disease treatments developer Poolbeg Pharma (LON: POLB) received a positive response from the US Patents and Trademarks Office concerning its application for POLB001. Chief executive Jeremy Skillington subsequently bought an initial 718,733 shares at 4.78p each. Over the week the share price improved 46.6% to 6.45p.

Abingdon Health (LON: ABDX) shares bounced back after a judgement in relation to judicial review proceedings against the Department of Health and Social Care found that there was nothing wrong with the contracts awarded to the diagnostic tests company. The shares jumped 44% to 9p.

==========

Fallers

PCF Group (LON: PCF) was the worst performer last week after it suspended new lending by PCF Bank while it is trying to raise additional finance. Last week, Castle Trust Capital decided not to bid for PCF. Sales of assets and other options to raise money are being considered. There will be further cost cutting. The shares have fallen by 44.4% to 1.25p.

Two deals were not completed by student accommodation and build to rent developer Watkin Jones (LON: WJG) before the end of September and they have knocked at least 10% off 2021-22 profit to around £49m. The dividend could be trimmed to 7.8p a share, so that it is still twice covered by expected earnings. There are also cost pressures and interest rate rises will hamper future profitability. There was a one-third cut in 2022-23 pre-tax profit forecast to £50m as a precaution. Demand for student accommodation and build to rent property remains strong but margins will come under pressure. Net cash is £75m. The share price has slumped by 40.5% to 90p. Directors bought shares at between 101p and 102.25p each.

Tortilla Mexican Grill (LON: MEX) increased interim revenues by 30% to £26.9m, including like-for-like growth of 19%. The restaurants operator reported a slump in pre-tax profit from £2.63m to £264,000. That was mainly down to a reduction in government assistance from £1.88m to £211,000, plus costs relating to the Chilango acquisition. There has also been general cost inflation. The opening programme is ahead of target, but sales during the summer were disappointing. The share price has dived 29.1% to 103.5p.

There were three trades in Craven House Capital (LON: CRV) last week. It appears that Tuesday’s trade at 15 cents a share was behind the 28.9% drop in the share price to 16 cents a share.

Mobile content and data company Mobile Streams (LON: MOS) launched a placing and subscription raising £1.2m at 0.18p a share, which was a one-third discount to the market price. The shares have fallen 28.8% to 0.185p. A broker option enable existing shareholders to invest an additional £200,000 – there was demand for £400,000 worth of shares. The new shares come with warrants exercisable at 0.3p each. The cash will go towards NFT contracts. GTCR is no longer considering a bid for GB Group (LON: GBG) and the shares have fallen 23% to 469.2p.

Innovative Eyewear shares fly as corporate presentation released

Innovative Eyewear, a portfolio company of Tekcapital, saw its shares fly on Friday after the release of an updated corporate presentation.

The presentation had been updated to include details of the recent agreement with Nautica, a global lifestyle brand.

Innovative Eyewear shares were 93% higher at $3.15 at the time of writing on Friday.

Innovative Eyewear and their Lucyd smart eyewear technology is targeting a $28.3 billion total addressable eye wear market with blue-tooth enabled products.

Lucyd has 44 granted and pending patents, and having recently announced an agreement with Nautica, secured a formidable partner to accelerate distribution to end users.

Despite the challenging market conditions, Innovative Eyewear completed a successful listing on the NASDAQ raising $7.4m in August.

Tekcapital, the majority shareholder of Lucyd, saw their shares rise 8% in London as a result of the move in LUCY shares.

AIM movers: Oxford Biodynamics premium placing

0

Oxford Biodynamics (LON: OBD) is raising £9.1m via a placing at 20p a share and a further £2.95m could be raised through a one-for- 6.81644 open offer. The share price rose 22% to 18.3p. This cash will help to fund the commercial development of the EpiSwitch CiRT technology.

Abingdon Health (LON: ABDX) shares bounced back after the diagnostic tests company said a judgement in relation to judicial review proceedings against the Department of Health and Social Care is expected at 3pm. Abingdon Health is an interested party in the case. The shares have jumped 50% to 9.75p.

Richard Teatum has taken a 8.92% stake in retailer Joules Group (LON: JOUL). The share price rose 24.2% to 9.51p. He is a director of companies involved motor cars and parts retail, an advertising agency and Darrington Golf Club.

Director buying is helping the TPXimpact (LON: TPX) share price to recover a small proportion of its losses since the trading statement. Outgoing chief executive Neal Gandhi bought 49,000 shares at 40.5p and 171,000 shares at 35p each. Other directors have also been buying shares including Steve Winters who has acquired an initial 150,000 shares this week in two tranches at 36p a share and 41p a share. The shares have increase 17.3% to 47.5p.

ReNeuron (LON: RENE) says its newly named platform CustomEx has demonstrated an improved competitive profile beyond its tropism (natural affinity advantage) and other advantages. The new data shows improved exosome uptake in three tissue types and a higher level of siRNA delivery versus the rival HEK cell-generated exosomes. The share price is 5.77% higher at 27.5p, having been 28.5p earlier. They have fallen by two-thirds this year.

There has been a mineral resource upgrade at the Amapa iron project in Brazil, even so 27% shareholder Cadence Minerals (LON: KDR) is the worst performer on the day with a 13.5% decline. The updated resource at Amapa is 276Mt grading 38.33% Fe, up from 177Mt. The measured resource is 55Mt grading 39.26% Fe.  

Liontrust has disposed of its 10.1% stake in musicMagpie (LON: MMAG) during the past week. The share price fell a further 8.51% to 12.9p.

Tertiary Minerals (LON: TYM) has completed the sale of its royalty interests in the Kaaresselkä and Kiekerömaa properties in Finland to Aurion Resources Ltd. Tertiary Minerals has received C$200,000 in cash and 83,333 shares in Aurion. The Tertiary Minerals share price was 5.77% lower at 0.245p.

FTSE 100 outperforms US and European equities after Non-Farm Payrolls

September’s Non-Farm Payrolls provided a hawkish twist on Friday as investors accessed the health of the US jobs market and the impact on the trajectory of interest rate hikes.

The FTSE 100 had been tentatively higher before the jobs number a turned negative shortly after the release, but outperformed US and European stocks.

US jobs data revealed 263,000 increase in jobs in September versus economist estimates of 255,000 and a prior number of 315,000.

The Non Farm Payrolls will present the Fed with a major headache as they are forced to choose between supporting a slowing jobs market and combating soaring inflation.

Early indications are markets feel the jobs data will not be enough to cause a Fed ‘pivot’ away from interest hikes in the short-term. There are expectations the Fed will hike 75 bps at their next meeting.

Price action in the dollar drove the initial reaction as GBP/USD dipping to 1.1123. The stronger dollar in the run up to the data has taken cable down from 1.1500 just three trading sessions ago.

The jobs reading all but confirmed additional rate hikes and equity markets reacted by immediately selling equities. US futures extended declines with the NASDAQ down 1.2% and S&P 500 off 0.5%.

The weaker pound provide some support for the FTSE 100 as it outperformed US and European indices, slipping 0.3% to 6,970 at the time of wiring.

A close above 7,000 would have been a major psychological boost to investors in UK equities in the short-term.

The FTSE 100 has rebounded from the worst levels since the government’s mini-budget, but is still about 5% down from recent highs. Defensive names and a leading towards UK banks benefitting from higher rates has supported the index, as have overseas earners enjoying a weaker pound.